Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China · Delayed Price · Currency is CNY 9.84
-0.22 (-2.19%)
Jun 2, 2026, 3:04 PM CST
SHE:300434 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 184.79 | 131.62 | 91.76 | 126.2 | 218.79 | 66.48 |
Depreciation & Amortization | 102.43 | 102.43 | 104.53 | 94.41 | 91.32 | 87.12 |
Other Amortization | 2.85 | 2.85 | 1.98 | 2.13 | 3.36 | 1.59 |
Loss (Gain) From Sale of Assets | -0.17 | -0.17 | 0.02 | -0.25 | -17.77 | 0 |
Asset Writedown & Restructuring Costs | 0.35 | 0.35 | 4.87 | 68.3 | 1.4 | 25.89 |
Loss (Gain) From Sale of Investments | 1.03 | 1.03 | 11.35 | 18.43 | 11.97 | 9.67 |
Provision & Write-off of Bad Debts | -0.73 | -0.73 | 0.56 | -0.9 | 2.08 | 4.26 |
Other Operating Activities | -65.1 | 2.61 | 5.19 | -10.13 | 0.82 | 4.28 |
Change in Accounts Receivable | -15.34 | -15.34 | -34.45 | 88.62 | -109.55 | -220.68 |
Change in Inventory | -3.04 | -3.04 | 24.45 | -41.05 | 20.09 | -30.38 |
Change in Accounts Payable | -4.28 | -4.28 | -45.98 | -183.04 | 106.14 | 198.3 |
Operating Cash Flow | 193.34 | 207.89 | 158.15 | 151.14 | 323.04 | 136.4 |
Operating Cash Flow Growth | -18.33% | 31.45% | 4.64% | -53.21% | 136.84% | 2.56% |
Capital Expenditures | -82.78 | -99.57 | -72.92 | -66.1 | -54.15 | -85.36 |
Sale of Property, Plant & Equipment | 1.74 | 0.42 | 1.29 | 3.16 | 0.71 | 0.15 |
Cash Acquisitions | - | - | - | - | - | -201.01 |
Investment in Securities | -55.47 | -201.92 | -146.87 | -78.51 | -9.97 | 19.94 |
Other Investing Activities | 2.29 | 1.06 | 1.74 | 0.95 | 2.25 | 0.68 |
Investing Cash Flow | -134.22 | -300.02 | -216.76 | -140.5 | -61.16 | -265.61 |
Short-Term Debt Issued | - | - | - | - | 15 | - |
Long-Term Debt Issued | - | 68 | 85 | 117.61 | - | - |
Total Debt Issued | 68 | 68 | 85 | 117.61 | 15 | - |
Short-Term Debt Repaid | - | - | - | - | -5 | -46 |
Long-Term Debt Repaid | - | -69.43 | -111.32 | -17.65 | -0.04 | -0.28 |
Total Debt Repaid | -69.43 | -69.43 | -111.32 | -17.65 | -5.04 | -46.28 |
Net Debt Issued (Repaid) | -1.43 | -1.43 | -26.32 | 99.96 | 9.96 | -46.28 |
Common Dividends Paid | -28.57 | -28.65 | -45.21 | -0.74 | -0.11 | -0.33 |
Other Financing Activities | 3.12 | 3.17 | 0.9 | -0.64 | -71.7 | - |
Financing Cash Flow | -27.78 | -26.91 | -70.63 | 98.57 | -61.86 | -46.61 |
Foreign Exchange Rate Adjustments | -1.95 | -0.94 | 0.58 | 0.46 | 1.48 | -0.21 |
Net Cash Flow | 29.38 | -119.97 | -128.66 | 109.68 | 201.5 | -176.04 |
Free Cash Flow | 110.56 | 108.32 | 85.23 | 85.04 | 268.89 | 51.03 |
Free Cash Flow Growth | -24.20% | 27.10% | 0.22% | -68.37% | 426.92% | -47.88% |
Free Cash Flow Margin | 10.25% | 10.43% | 7.73% | 7.03% | 21.64% | 4.84% |
Free Cash Flow Per Share | 0.28 | 0.27 | 0.21 | 0.21 | 0.66 | 0.13 |
Cash Income Tax Paid | 136.96 | 132.58 | 162.04 | 262.23 | 100.93 | 111.54 |
Levered Free Cash Flow | -102.7 | -89.98 | 122.31 | 77.09 | 263.72 | 27.39 |
Unlevered Free Cash Flow | -102 | -89.26 | 123.13 | 77.51 | 264 | 27.4 |
Change in Working Capital | -32.09 | -32.09 | -62.12 | -147.05 | 11.08 | -62.9 |